Skip to content

Analysis of Adverse Drug Reactions of Drug-Induced Gastrointestinal Bleeding

Analysis of Adverse Drug Reactions of Drug-Induced Gastrointestinal Bleeding

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119063
Enrollment
Unknown
Registered
2026-02-14
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal bleeding

Interventions

Drug induced gastrointestinal bleeding group:None

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 93 Years

Inclusion criteria

Inclusion criteria: 1. A clear history of drug use and gastrointestinal bleeding; 2. Noah's Adverse Reaction Assessment Scale score >=1

Exclusion criteria

Exclusion criteria: 1.Patients with gastrointestinal haemorrhage due to disease progression

Design outcomes

Primary

MeasureTime frame
Haemoglobin level at the time of consultation;

Countries

China

Contacts

Public Contacttangdehong

Huzhou Center Hospital

tangdehong8272@163.com+86 572 2555339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026